TipRanks
Immunovant (DE:4YB)
STUTTGART:4YB

Compare Immunovant (4YB) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Immunovant
―
€5.92B
-11.36
7 Buy
3 Hold
0 Sell
Moderate Buy
TG Therapeutics
$55.42
$7.99B
17.39
45.07%
5 Buy
0 Hold
1 Sell
Moderate Buy
Viridian Therapeutics
$24.18
$2.06B
-5.18
-12.95%
12 Buy
0 Hold
0 Sell
Strong Buy
Aurinia Pharmaceuticals
$16.75
$2.09B
6.78
36.72%
2 Buy
1 Hold
0 Sell
Moderate Buy
Protagonist Therapeutics
$150.59
$8.97B
115.69
115.24%
12 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$125.55
$8.81B
-33.34
90.35%
13 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:4YB
Immunovant
―
―
―
TGTX
TG Therapeutics
52.95
17.20
48.11%
VRDN
Viridian Therapeutics
18.28
-3.08
-14.42%
AUPH
Aurinia Pharmaceuticals
16.01
4.48
38.86%
PTGX
Protagonist Therapeutics
140.92
75.62
115.80%
KYMR
Kymera Therapeutics
108.35
52.06
92.49%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts